Converge Bio

🗓 Founded 2024👥 49 employees💰 Last funded Sep 2025
Biotechnology Research🌐 converge-bio.com
Website LinkedIn
Converge Bio is at the forefront of integrating Generative AI with biological data. Our mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of Large Language Models (LLMs) specifically trained on biological languages.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Israel
2
Frequently asked questions
Who invested in Converge Bio?
Converge Bio has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Converge Bio last raise funding?
The most recent investment in Converge Bio recorded on gritt.io was in September 2025.
When was Converge Bio founded?
Converge Bio was founded in 2024.
What industry is Converge Bio in?
Converge Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.